Table 1 The PALB2 variants with in silico assessment by prediction tools.

From: Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2

Location

DNA change

Protein change

Number of heterozygotes in all BCa cases (%)

Number of heterozygotes in Familial BCa cases (%)

Number of heterozygotes in Sporadic BCa cases (%)

SIFT prediction

Align GVGD prediction

Polyphen-2 prediction

Exon 1

c.47 A > T

p.K16M

1 (0.04)

-

1 (0.05)

Damaging (0)

Class C0

Probably Damaging (1)

Exon 2

c.72 G > C

p.L24F

1 (0.04)

1 (0.33)

-

Damaging (0)

Class C15

Probably Damaging (1)

Exon 2

c.103 C > T

p.L35F

1 (0.04)

1 (0.33)

-

Damaging (0)

Class C15

Probably Damaging (1)

Exon 4

c.457 A > T

p.R153W

1 (0.04)

-

1 (0.05)

Damaging (0.01)

Class C0

Probably Damaging (0.997)

Exon 4

c.1213 C > G

p.P405A

13 (0.57)

3(0.98)

10 (0.51)

Damaging (0)

Class C25

Probably Damaging (1)

Exon 5

c.1884G > T

p.K628N

1 (0.04)

-

1 (0.05)

Damaging (0.02)

Class C0

Probably Damaging (0.998)

Exon 5

c.1987C > T

p.R663C

1 (0.04)

-

1 (0.05)

Damaging (0)

Class C15

Probably Damaging (0.995)

Exon 10

c.3035 C > T

p.T1012I

4 (0.18)

1 (0.33)

3 (0.15)

Damaging (0)

Class C15

Probably Damaging (1)

Exon 10

c.3054 G > C

p.E1018D

33 (1.45)

4 (1.30)

29 (1.47)

Damaging (0.02)

Class C0

Probably Damaging (0.998)

Exon 12

c.3296 C > T

p.T1099M

2 (0.08)

-

2 (0.10)

Damaging (0)

Class C15

Probably Damaging (1)

  1. BCa Breast cancer.